Фемара

Фемара (Letrozole) is an oral aromatase inhibitor used primarily in hormone receptor-positive breast cancer therapy. This medication helps reduce estrogen levels in postmenopausal women, supporting treatment goals. Suitable for prescription-based regimens.

Фемара (Letrozole) is prescribed to reduce estrogen production in postmenopausal women, often used in breast cancer treatment. It may also be used off-label for fertility support in ovulation induction. Commonly discussed as 'what is letrozole used for' in clinical contexts.

Фемара (Letrozole) works by lowering estrogen levels in the body, which can impact hormone-sensitive conditions. Users may experience changes related to hormonal balance during treatment. Individual responses vary based on medical history and concurrent therapies.

Always take Фемара (Letrozole) exactly as prescribed by a healthcare provider. Discuss any history of osteoporosis, liver disease, or high cholesterol before starting treatment. Regular monitoring may be recommended to assess treatment progress and safety.

Фемара (Letrozole) may interact with other medications affecting estrogen levels or liver enzymes, such as tamoxifen or CYP inhibitors. Alcohol use should be discussed with a doctor, as it may influence treatment effects. Always inform your healthcare provider about all medications being taken.